MCRB
Seres Therapeutics Inc
2.70$
+3.0%
vs. previous close
Closing price · As of: Oct 9, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 16 | Q4 16 | Q1 17 | Q2 17 | Q3 17 | Q4 17 | Q1 18 | Q2 18 | Q3 18 | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -76.7% | -0.7% | 0.0% | +663.6% | -86.7% | +29.9% | +16.1% | +96.3% | +17.4% | -31.1% | +71.2% | -43.9% | +8.4% | +7.4% | -26.2% | -76.6% | +1,139.5% | -67.4% | -8.0% | +2,307.8% | -94.3% | -79.3% | -18.6% | +183.2% | -71.7% | -153.5% | – | -99.8% | -79.4% | -100.0% | – | – | – | -100.0% | – | – | +24.8% | -18.3% | +105.6% | – | |
| – | -16.1% | -0.6% | +14.5% | -3.7% | +8.2% | -2.4% | +2.5% | -1.6% | +4.6% | -7.6% | -21.8% | +2.3% | +14.8% | +3.4% | -7.6% | +18.7% | +4.2% | +17.8% | +22.7% | +10.9% | -7.8% | +7.9% | +10.8% | -1.9% | +7.2% | -4.9% | +6.4% | -89.9% | -14.6% | +381.0% | -92.7% | -1.1% | +265.2% | -31.2% | -70.0% | +1,160.8% | -203.4% | – | -100.0% | – | |
| – | – | – | – | – | -2,707.0% | – | – | – | – | – | – | – | – | – | -26.2% | -76.6% | -615.4% | – | – | – | -134.0% | – | – | – | – | – | – | -106.0% | – | -30,559.4% | – | – | – | – | – | – | – | -103.0% | – | – | |
| – | -16.1% | -0.6% | +14.5% | -3.7% | +8.2% | -2.4% | +2.5% | -1.6% | +4.6% | -7.6% | -21.8% | +2.3% | +14.8% | +3.4% | -7.6% | +18.7% | +4.2% | +17.8% | +22.7% | +10.9% | -7.8% | +7.9% | +10.8% | -1.9% | +7.2% | -4.9% | +6.4% | -46.2% | +6.7% | -27.4% | -18.9% | +4.1% | -22.0% | -7.9% | +9.5% | -2.5% | -7.4% | +12.9% | -30.7% | – | |
| – | +6.1% | +3.7% | -4.5% | -3.0% | +8.3% | -0.1% | -0.9% | -12.7% | -0.8% | -0.5% | -25.6% | +5.8% | -2.0% | +6.2% | +5.8% | +16.3% | +40.3% | +10.8% | +48.6% | +12.1% | +4.8% | -9.4% | +9.5% | -9.6% | +21.9% | +0.3% | +24.8% | -30.7% | -11.3% | -13.3% | -12.6% | -2.7% | -2.0% | -4.6% | -13.8% | -7.6% | -20.4% | +7.0% | -12.5% | – | |
| – | -10.6% | +0.7% | +8.7% | -3.5% | +8.2% | -1.8% | +1.6% | -4.5% | +3.3% | -5.9% | -22.7% | +3.1% | -76.1% | +382.2% | -4.6% | +18.1% | -66.3% | +10.8% | +48.6% | +5.6% | +7.9% | -11.6% | +17.1% | -5.7% | +18.7% | +13.1% | +15.6% | +32.1% | -0.6% | -62.3% | +93.2% | -3.8% | -14.6% | +0.0% | +0.5% | -60.2% | +254.8% | -39.1% | +7.4% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -172.3% | – | – | – | – | – | – | -190.0% | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +11.9% | +2.9% | -100.0% | – | +1,192.7% | -78.2% | -100.0% | – | +347.3% | -81.2% | -14.1% | +77.2% | +49.9% | +42.6% | +0.4% | +1.5% | +4.0% | -8.3% | +5.2% | +1.6% | -0.8% | +23.6% | +64.6% | +15.1% | +8.9% | +3.6% | +63.6% | +25.9% | +0.4% | +15.7% | -26.1% | -100.0% | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -173.3% | – | – | – | – | – | – | -188.1% | – | – | – | – | – | – | -160.8% | – | -286.9% | – | – | – | |
| – | +3.8% | -435.8% | – | – | – | -100.0% | – | – | – | – | – | – | – | – | +10.2% | -10.0% | -48.7% | -47.9% | +55.7% | +58.6% | -816.8% | – | +37.1% | +41.5% | -71.1% | +23.9% | -75.4% | +866.4% | -252.4% | – | -100.0% | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -173.3% | – | – | – | – | – | – | -202.8% | – | – | – | – | -117.6% | – | -160.8% | – | -286.9% | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -167.7% | – | – | – | – | – | – | -176.7% | – | – | – | – | – | – | -155.7% | – | -242.5% | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Showing the most recent 40 periods — older statements are on file for this stock.
Data as of: October 9, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.